Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for chronic pain after hepatectomy
NCT05492669Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic post-surgical pain (CPSP), sponsored by West China Hospital of Sichuan University. Started Feb 2020; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic post-surgical pain (CPSP)
Beyond the preview
Go deeper on NCT05492669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05492669.